Top

Published in:

01-09-2010 | Original Article

Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma

Authors: Hideshi Sugiura, Yasuhiro Fujiwara, Masashi Ando, Akira Kawai, Akira Ogose, Toshifumi Ozaki, Ryohei Yokoyama, Toru Hiruma, Takeshi Ishii, Hideo Morioka, Hideo Mugishima

Published in: Journal of Orthopaedic Science | Issue 5/2010

Title: Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma
Authors: Hideshi Sugiura
Yasuhiro Fujiwara
Masashi Ando
Akira Kawai
Akira Ogose
Toshifumi Ozaki
Ryohei Yokoyama
Toru Hiruma
Takeshi Ishii
Hideo Morioka
Hideo Mugishima
Publication date: 01-09-2010
Publisher: Springer Japan
Published in: Journal of Orthopaedic Science / Issue 5/2010
Print ISSN: 0949-2658
Electronic ISSN: 1436-2023
DOI: https://doi.org/10.1007/s00776-010-1506-9

At a glance: The STEP trials

Springer Medicine

Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2010

Voiding dysfunction caused by an intrapelvic synovial cyst that resulted from a screw misplaced when fixing the metal cup during total hip arthroplasty

Distribution and role of tenascin-C in human osteoarthritic cartilage

Effect of periacetabular osteotomy for acetabular dysplasia clarified by three-dimensional finite element analysis

Allogeneic and autologous stem cell transplantation in advanced small round cell sarcomas

Orthopedic research in the final year of the Bone and Joint Decade

Insufficiency fractures of bilateral distal tibias associated with chronic liver disease